guidelines pharmacologic therapy weight regain after bariatric surgery glp-1 maintenance discontinuation of therapies GLP1 After Bariatric Surgery: What

Coverage strategies should contemplate how long members are likely to remain on therapy, under what conditions treatment continues, and how to respond if members stoprecognizing that discontinuation is common in realworld settings and typically followed by rapid weight regain

Mounjaro (tirzepatide) is a prescription medicine licensed in the UK for the treatment of type 2 diabetes and, more recently, for weight management in adults with obesity or overweight with weight-related health conditions

19, e202100960

As the chart below illustrates, these can range from cardboardy notes to metallic and bitter notes, and much depending on the ingredients

Compounded semaglutide( Ozempic and Wegovy) and compounded tirzepatide (Zepbound and Mounjaro) are GLP-1 medications